Business
NOLA_B: 3% organic growth and resilient margins in Q1, with margin normalization expected by Q3
NOLA_B: 3% organic growth and resilient margins in Q1, with margin normalization expected by Q3
About this update from Nolato Ab Class B
Q1 2026 saw 3% organic sales growth and stable margins despite currency and input cost headwinds. Medical Solutions led growth, while Engineered Solutions benefited from strong materials and electronics demand. Margin normalization is expected by Q3 as cost increases are passed on.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.